Detalhe da pesquisa
1.
The Complex Network of Cytokines and Chemokines in Pediatric Patients with Long-Standing Type 1 Diabetes.
Int J Mol Sci
; 25(3)2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38338843
2.
Combined therapy with CD4+ CD25highCD127- T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I/II trial.
Diabetes Obes Metab
; 24(8): 1534-1543, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35441440
3.
GPA33: A Marker to Identify Stable Human Regulatory T Cells.
J Immunol
; 204(12): 3139-3148, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366581
4.
Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents.
J Enzyme Inhib Med Chem
; 37(1): 2725-2741, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36189734
5.
Regulatory T Cells-Related Genes Are under DNA Methylation Influence.
Int J Mol Sci
; 22(13)2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34281195
6.
Antigen-reactive regulatory T cells can be expanded in vitro with monocytes and anti-CD28 and anti-CD154 antibodies.
Cytotherapy
; 22(11): 629-641, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32778404
7.
Therapy with CD4+CD25+ T regulatory cells - should we be afraid of cancer?
Contemp Oncol (Pozn)
; 23(1): 1-6, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31061630
8.
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.
J Transl Med
; 14(1): 332, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27903296
9.
Synthesis and biological activity of ester derivatives of mycophenolic acid and acridines/acridones as potential immunosuppressive agents.
J Enzyme Inhib Med Chem
; 31(6): 974-82, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26308114
10.
Synthesis of the inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
J Enzyme Inhib Med Chem
; 30(4): 550-63, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25198892
11.
Approaches Towards Better Immunosuppressive Agents.
Curr Top Med Chem
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561615
12.
PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration.
Int Immunopharmacol
; 132: 111919, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554443
13.
Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity.
Front Immunol
; 14: 1321228, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38283365
14.
Antigenic Challenge Influences Epigenetic Changes in Antigen-Specific T Regulatory Cells.
Front Immunol
; 12: 642678, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33868279
15.
Administration of CD4+CD25highCD127-FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study.
BioDrugs
; 35(1): 47-60, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400237
16.
Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.
BMJ Open Diabetes Res Care
; 8(1)2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32098895
17.
Corrigendum: Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses.
Front Immunol
; 9: 343, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29493663
18.
Cell-Based Therapies with T Regulatory Cells.
BioDrugs
; 31(4): 335-347, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28540499
19.
Investigations on the immunosuppressive activity of derivatives of mycophenolic acid in immature dendritic cells.
Int Immunopharmacol
; 44: 137-142, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28092865
20.
Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses.
Front Immunol
; 8: 1870, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29312346